MedPath

Comparison of the efficacy and tolerability of adapalene gel 0.1% versus tretinoin gel 0.05% in patients with mild to moderate acne vulgaris

Phase 2
Completed
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT201403109014N31
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Any patient with mild to moderate acne vulgaris without limitation of age and gender.
Exclusion criteria: (a) Pregnancy or breast feeding; (b) using medication that have interaction with the drug under study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.